Ovarian Cancer Treatment
卵巢癌治疗
Duration
4-8 months of combined treatment
Recovery
4-6 weeks after surgery, chemotherapy cycles span 4-6 months
Savings
~79% vs US
Average savings compared to US prices
Ovarian cancer treatment in China combines radical cytoreductive surgery with platinum-based chemotherapy, often incorporating targeted therapies like PARP inhibitors and bevacizumab. Leading Chinese oncology centers such as Fudan University Cancer Hospital and Peking University People's Hospital achieve outcomes comparable to international standards with specialized gynecologic oncology teams. Advanced genetic testing (BRCA1/2) guides personalized treatment selection for optimal response.
Staging & Genetic Testing
CT/MRI imaging, CA-125 marker testing, and BRCA genetic analysis to determine stage and treatment plan
Duration: 1-2 weeksCytoreductive Surgery
Radical debulking surgery to remove all visible tumor including affected organs if necessary
Duration: 3-6 hoursChemotherapy Cycles
6 cycles of carboplatin/paclitaxel administered every 3 weeks, with possible HIPEC
Duration: 4-5 monthsMaintenance Therapy
PARP inhibitors or bevacizumab as maintenance for patients with specific genetic profiles
Duration: 1-2 years- Comprehensive multidisciplinary treatment approach
- Access to PARP inhibitors and targeted therapies
- Genetic-guided personalized treatment selection
- Significantly lower costs than Western countries
- Surgical complications including bleeding and infection
- Chemotherapy side effects (nausea, neutropenia, neuropathy)
- Risk of recurrence particularly in advanced stages
- Emotional and psychological impact of treatment
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.